Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2015

Jan 20, 2015

5262_dirs_2015-01-20_20615484-be5d-40db-bd19-1cb971d51241.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6687C

GlaxoSmithKline PLC

20 January 2015

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc ('GSK') was advised on 16 January 2015, of changes in the interests of the following Person Discharging Managerial Responsibilities, following increases in their actual and notional interests in American Depositary Shares (ADSs), at a price of $41.78 per ADS, following the re-investment of dividends paid on ADSs held in the unvested portion of GSK 2009 Deferred Annual Bonus Plan Post-Tax awards and matching elements.

Director/PDMR Number of actual ADSs acquired under the personal contribution element of the plan Number of notional ADSs acquired  under the matching element of the plan
Mrs D P Connelly 51.56 51.64

The notional dividends accrued will be paid out in proportion to the percentage of the participant's deferred annual bonus holdings that will vest following the end of the relevant measurement period.

V A Whyte

Company Secretary

20 January 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSEBLFLEFFXBBL